Skip to content

NOVAVAX INC

NVAX

CIK 0001000694

← back to feed
Revenue (TTM)
$1.12B
+64.7% YoY Q1 Apr 2026
Net Income (TTM)
$413.28M
+334.8% YoY Q1 Apr 2026
EPS Diluted (TTM)
$2.24
+309.8% YoY Q1 Apr 2026
Gross Margin
92.7%
Q1 Apr 2026
Operating Margin
37.9%
Q1 Apr 2026
Net Margin
37.0%
Q1 Apr 2026
Free Cash Flow (TTM)
—
Q1 Apr 2026
Cash
$228.36M
Q1 Apr 2026
Total Debt
$291.43M
Q1 Apr 2026
Shares Outstanding
164.44M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings